Richard Kuntz, M.D., M.Sc.
DirectoratDiaMedica Therapeutics· In proxies 2023–2024
Richard Kuntz, M.D., M.Sc. is Director of DiaMedica Therapeutics.
Experience
- DiaMedica TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +542%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?